文献速递消化、代谢与肾脏急症重症综合管理与镇静镇痛

急诊停留时间延长对脓毒症抗生素再次给药延迟及结局的影响

Impact of extended emergency department stay on antibiotic re-dosing delays and outcomes in sepsis.
PubMed 文献 · Am J Emerg Med · 2022-02-24
一句话结论脓毒症患者急诊停留≥6小时与<6小时相比,第二剂抗生素延迟发生率无统计学差异,但两组延迟发生率均较高,提示需改善急诊脓毒症患者的诊疗衔接。

本研究为回顾性队列研究,纳入2018年3月至2020年2月期间从急诊收治的≥18岁脓毒症或脓毒性休克患者128例,比较急诊停留时间<6小时组(99例)与≥6小时组(29例)第二剂抗生素延迟的发生率及结局。结果显示两组第二剂抗生素延迟发生率分别为30.3%与24.1%(p=0.52),无统计学差异;次要结局亦无显著差异。探索性分析中,有再次给药延迟者院内死亡率数值上高于无延迟者(18.9% vs. 8.8%,p=0.11)。作者认为两组延迟发生率均较高,提示需改善急诊脓毒症人群的诊疗衔接。

要点

  • 急诊停留≥6小时组第二剂抗生素延迟发生率为24.1%,<6小时组为30.3%,两组比较p=0.52,无统计学差异。
  • 两组在ICU停留时间、住院时间、非ICU转ICU率、机械通气发生率及持续时间、院内死亡率等次要结局上均无显著差异。
  • 探索性分析显示,有再次给药延迟者院内死亡率为18.9%,无延迟者为8.8%,p=0.11,未达统计学显著。
  • 两组抗生素再次给药延迟发生率均较高,作者认为提示需改善急诊脓毒症人群的诊疗衔接。
  • 研究为回顾性队列,样本量128例,其中急诊停留≥6小时组仅29例。

适用人群与场景

  • 2018年3月至2020年2月期间从急诊收治的≥18岁脓毒症或脓毒性休克患者。

研究设计与关键结果

  • 研究类型:回顾性队列研究,比较急诊停留时间<6小时组(99例)与≥6小时组(29例),共纳入128例患者。
  • 主要结局:第二剂抗生素延迟在急诊停留<6小时组发生30例(30.3%),在≥6小时组发生7例(24.1%),p=0.52。
  • 次要结局:ICU停留时间、住院时间、非ICU转ICU率、机械通气发生率及持续时间、院内死亡率在两组间均无显著差异。
  • 探索性分析:有再次给药延迟者院内死亡率为18.9%,无延迟者为8.8%,p=0.11。

证据类型、等级与局限

  • 证据类型:回顾性队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,两组抗生素再次给药延迟发生率均较高,提示需改善急诊脓毒症人群的诊疗衔接。
  • 研究未发现急诊停留≥6小时与第二剂抗生素延迟存在统计学显著关联,也未发现与次要结局的显著关联。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: For patients with sepsis and septic shock, the initial administration of antibiotics should occur as soon as possible, preferably within one hour of sepsis recognition. While clinicians are focused on providing first-doses of antibiotics quickly upon presentation, re-dosing issues may arise in patients who have an extended emergency department (ED) length of stay (LOS). Limited studies have been conducted that assess the impact of re-dosing delays. The purpose of this study was to assess the association of an extended ED LOS ≥ 6 h with antibiotic re-dosing delays in patients with sepsis and examine outcomes.

METHODS: A retrospective cohort study comparing patients with sepsis with an ED LOS of <6 h to those with an ED LOS of ≥6 h was performed between March 2018 and February 2020. Patients ≥18 years old admitted from the ED with sepsis or septic shock were included. The primary outcome was incidence of delay to the second dose of antibiotics in those with an extended ED LOS compared to those without. Secondary outcomes included intensive care unit (ICU) LOS, hospital LOS, rate of transfer from non-ICU to ICU settings, incidence and duration of mechanical ventilation, and in-hospital mortality. An exploratory analysis compared outcomes in patients with and without a re-dosing delay.

RESULTS: Of the 128 patients included, 99 patients had an ED LOS < 6 h and 29 patients had an ED LOS ≥ 6 h. A delay to second dose of antibiotics occurred in 30 (30.3%) patients in the ED LOS < 6 h group versus 7 (24.1%) patients in the ED LOS ≥ 6 h group (p = 0.52). Secondary outcomes did not significantly differ between the two groups. In-hospital mortality was numerically higher in those with a re-dosing delay when compared to those without in the exploratory analysis (18.9% vs. 8.8%, p = 0.11).

CONCLUSION: There was no statistically significant difference in the incidence of delays to the second dose of antibiotics among patients with sepsis with an ED LOS of <6 h versus those with an ED LOS of ≥6 h. The high incidence of antibiotic re-dosing delays in both groups, indicates an overall need for improved transitions of care in the ED sepsis population.

来源:Am J Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Harpenau TL, Bhatti SN, Hoffman BM, et al. Impact of extended emergency department stay on antibiotic re-dosing delays and outcomes in sepsis. Am J Emerg Med. 2022. PMID: 35255455. doi:10.1016/j.ajem.2022.02.028

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。